Overcoming Inertia to Tame the Red Devil
- PMID: 34396165
- PMCID: PMC8352249
- DOI: 10.1016/j.jaccao.2019.08.011
Overcoming Inertia to Tame the Red Devil
Keywords: anthracyclines; breast cancer; cardioprotection; dexrazoxane; heart failure.
Comment on
- doi: 10.1016/j.jaccao.2019.08.003
References
-
- Howlader N, Noone AM, Krapcho M, et al., editors. Table 4.17. Cancer of the female breast (invasive). In SEER cancer statistics review, 1975-2016. Bethesda, MD: National Cancer Institute. Available at: https://seer.cancer.gov/csr/1975_2016/browse_csr.php?sectionSEL=4&pageSE.... Accessed on August 21, 2019.
-
- Cancer Research UK Breast Cancer Statistics. www.cancerresearchuk.org Available at: Accessed on July 31, 2019.
-
- Curado M.P., Edwards B., Shin H.R. IARC Press; Lyon, France: 2007. Cancer incidence in five continents, vol. IX. IARC scientific publications no. 160.
-
- Levine M.N., Bramwell V.H., Pritchard K.I. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. J Clin Oncol. 1998;16:2651–2658. - PubMed
-
- Saloustros E., Mavroudis D., Georgoulias V. Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opin Pharmacother. 2008;9:2603–2616. - PubMed